IMIDomics, Inc. Announces Strategic Investment from Drug Discovery and Research Leader Evotec SE
IMIDomics, Inc., a privately held global biotechnology company focused on the discovery and development of new targets and medicines for the treatment of patients with immune-mediated inflammatory diseases
Source: finanznachrichten.de